Welcome to our dedicated page for ALT5 Sigma Corporation SEC filings (Ticker: ALTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ALT5 Sigma Corporation (NASDAQ: ALTS) files a range of reports with the U.S. Securities and Exchange Commission that document its fintech operations, digital asset treasury strategy, governance changes, and financial reporting status. On this page, investors can review ALT5’s Forms 10-K and 10-Q, along with current reports on Form 8-K and other disclosures, with AI-powered summaries that help explain key points from each filing.
ALT5’s periodic reports, such as the Form 10-K annual report and Form 10-Q quarterly reports, provide detail on its Fintech & Payments segment, $WLFI Treasury segment, and legacy biotech business. These filings describe how the company presents its digital asset payments, trading, and settlement infrastructure, as well as its holdings of $WLFI tokens and exposure to the USD1 stablecoin ecosystem. They also include discussions of risk factors, accounting policies, and segment information relevant to understanding ALTS as a fintech and digital asset-focused issuer.
The company’s Form 8-K filings offer timely updates on material events. Recent 8-Ks have covered topics such as changes in executive leadership, appointment of a new independent registered public accounting firm, Nasdaq filing delays and related communications, settlements of litigation involving unauthorized access to company information, and stockholder votes to increase authorized share capital. These reports provide context on corporate governance, control environment, and significant legal or strategic developments.
Through this SEC filings page, users can access real-time updates from EDGAR, including Form 4 insider transaction reports when available, and use AI-generated insights to quickly understand lengthy documents like 10-Ks and 10-Qs. This helps investors analyze how ALT5 manages its digital asset treasury, reports on its payments and settlement platforms, and addresses regulatory and governance matters that appear in its official filings.
ALT5 Sigma Corporation filed an amended quarterly report for the quarter ended September 27, 2025, mainly to make limited technical changes. The amendment removes the second sentence in Item 1A, updates certain officer certification exhibits to reflect the company’s current name, and corrects a dating typo in other certification exhibits, with no other changes to the original report.
The company also discloses that on January 7, 2026 it received a delinquency notification letter from Nasdaq for not holding an annual stockholder meeting within twelve months of its fiscal year end. ALT5 Sigma plans to regain compliance by holding its Annual Meeting of Stockholders on February 27, 2026 and submitting a plan; Nasdaq’s framework allows until June 26, 2026 to cure the deficiency, and the notice has no immediate effect on the trading or listing of its common stock.
ALT5 Sigma Corporation reported a sharp swing to profitability as it scales its fintech and crypto-focused strategy. For the quarter ended September 27, 2025, revenue rose to $7.6 million from $4.9 million, driven by growth in its digital asset payment platforms and the inclusion of newly acquired Mswipe. Year-to-date revenue reached $19.5 million versus $7.1 million a year earlier.
The company posted quarterly net income of $49.0 million, compared with a loss of $0.8 million in the prior-year period. Results were heavily influenced by a $72.8 million unrealized gain on cryptocurrency assets tied to its WLFI treasury program, which held $1.53 billion of crypto assets at fair value on the balance sheet. Operating costs also rose sharply, with selling, general and administrative expenses at $19.2 million for the quarter.
ALT5 completed significant strategic moves, including the acquisitions of ALT5 Subsidiary and Mswipe, and a large equity financing that raised $750 million, much of which funded crypto purchases. Common shares outstanding expanded from 15.4 million at December 28, 2024 to 126.1 million at September 27, 2025. The biotechnology business, Alyea, is classified as discontinued operations as the company advances plans to separate those healthcare assets.
ALT5 Sigma Corporation reached a comprehensive settlement with Wellington Peel, LLC and related parties, resolving previously disclosed litigation and related disputes. As part of the agreement, all parties granted mutual releases of claims connected to those matters, and the earlier court action was withdrawn without prejudice.
To resolve a contractual dispute over a terminated consulting agreement, ALT5 Sigma agreed to pay Wellington Peel, LLC a total of $200,000, with $100,000 due at signing and $20,000 in five monthly installments starting in February 2026. The company will also issue 225,000 shares of common stock to Wellington Peel, LLC and its principal, and 50,000 shares to a former employee of its Canadian subsidiary in connection with a share award dispute. The settlement includes no admission of liability by any party, and ALT5 Sigma states it does not expect a material impact on its financial condition, results of operations, or cash flows.
ALT5 Sigma Corporation entered into a Separation Agreement and Mutual Release of Claims with former Chief Executive Officer Peter Tassiopoulos, under which his employment with the company and its affiliates, and his August 26, 2024 employment agreement, will conclude on December 15, 2025.
The company will pay him all salary and wages due and owing through that separation date, described as "Past Due Compensation," and after this payment it will have no further economic, compensatory or benefit related obligations to him. Both sides mutually release claims with no reference to or admission of wrongdoing. Mr. Tassiopoulos will also resign from the board of directors effective December 15, 2025, while agreeing to remain available for transition assistance, and the report is signed by Acting Chief Executive Officer Tony Isaac.
ALT5 Sigma Corporation appointed Victor Mokuolo, CPA PLLC as its new independent registered public accounting firm, effective December 8, 2025, for the fiscal year ending December 27, 2025.
The company states that during its two most recent fiscal years ended December 28, 2024 and December 30, 2023, and through December 8, 2025, it did not consult this firm on accounting principles, audit opinions, or other accounting matters, and there were no disagreements or reportable events of the type described in the relevant SEC disclosure items.
ALT5 Sigma Corporation announced several leadership changes and a board update. The Board ended the employment of Jonathan Hugh as Chief Financial Officer and Acting Chief Executive Officer, and plans to finalize his departure terms later. The company also notified Chief Operating Officer Ron Pitters that his consulting agreement will end in accordance with its terms, after which he will no longer serve as COO, though he remains on the Board.
The Board appointed Tony Isaac, already President and a director, as Acting Chief Executive Officer and designated him as principal executive officer, while he continues in his existing roles. The company also named Steven Plumb as Chief Financial Officer and principal accounting officer; under his offer, he will receive a base annual salary of $339,400, and the company expects to enter into a formal employment agreement with him. Director David Danziger resigned from the Board and its committees for personal reasons and not due to any disagreement with the company.
The Board passed a resolution to disband its Special Committee, which had been created to investigate certain matters previously disclosed. The facts and issues reviewed by the Special Committee and its advisors were presented to the full Board so it can continue to act in accordance with its fiduciary duties to shareholders.
ALT5 Sigma Corporation reported that it will not file its Quarterly Report on Form 10-Q for the quarter ended September 27, 2025 on time because it has not completed its review and reporting of those financial results. The company states that the delay arises from several factors, including issues it has previously described. ALT5 Sigma plans to update stockholders once it has more information about filing its third-quarter 2025 financial results and any related previously issued financial statements.
ALT5 Sigma Corp (ALTS) disclosed an initial beneficial ownership report. A director by deputization associated with World Liberty Financial, Inc. reported holdings and warrants.
The filer holds 1,000,000 shares of common stock (direct). Derivative positions include warrants for 8,000,000 shares at $7.50, 4,000,000 at $8.25, 4,000,000 at $9.00, and 4,000,000 at $9.75. These warrants are exercisable after issuance, have no expiration date, and are each subject to a 4.99% beneficial ownership limitation.
The filing also lists 99,000,000 pre‑funded warrants exercisable for common stock at an exercise price of $0.001 per share. These are subject to the same 4.99% cap and become exercisable from and after October 16, 2025 following stockholder approval to permit issuance above 19.99% under Nasdaq rules and an amendment increasing authorized common shares. WLFI is deemed a director by deputization through its representatives on the board.
ALT5 Sigma Corp (ALTS) filed a Form 3 reporting Zachary D. Witkoff’s initial beneficial ownership via World Liberty Financial, Inc. (WLFI). The filing lists 1,000,000 shares of common stock held indirectly.
It also reports derivative holdings subject to a 4.99% beneficial ownership limitation and no expiration: warrants for 8,000,000 shares at $7.50, 4,000,000 at $8.25, 4,000,000 at $9.00, and 4,000,000 at $9.75. In addition, there are 99,000,000 pre‑funded warrants at $0.001 per share, exercisable from October 16, 2025 after stockholder approval to permit issuance above 19.99% and an authorized share increase. WLFI is treated as a director by deputization, and Mr. Witkoff disclaims beneficial ownership except to the extent of any pecuniary interest.
ALT5 Sigma Corp (ALTS)Zachary Folkman. The filing lists 1,000,000 shares of common stock held indirectly through World Liberty Financial, Inc. (WLFI).
Indirect derivative positions include warrants for 8,000,000 shares at $7.50, 4,000,000 at $8.25, 4,000,000 at $9.00, and 4,000,000 at $9.75, all without expiration and exercisable subject to a 4.99% beneficial ownership limit. Pre-funded warrants for 99,000,000 shares at $0.001 are exercisable from October 16, 2025 after stockholder approvals and an authorized share increase. WLFI is noted as a director by deputization.